
BGF injects £6m into Medicina
The Business Growth Fund (BGF) has invested £6m in Bolton-based medical devices company Medicina.
The investment will be used to support new product development and expand the company in the UK and overseas markets.
BGF was introduced to the company by BTG Corporate Finance.
Company
Medicina produces enteral feeding devices such as syringes, tubes and pumps, which are used to provide nutrition to a patient, both in hospital and at home. Clients include the NHS and homecare companies.
Bolton-based Medicina was established by current CEO Ken Harrison in 1992.
People
As part of the deal, Galvin Mould has joined the company as non-executive chairman.
Neil Inskip is an investment manager at BGF and Andy Gregory is regional director for BGF's northern team.
Advisers
Equity - Baker Tilly (Financial due diligence); Squire Sanders (Legal).
Company - BTG Corporate Finance (Financial due diligence); Taylors (Legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater